loading

Bausch Health Companies Inc 주식(BHC)의 최신 뉴스

pulisher
Jun 02, 2025

The most oversold and overbought stocks on the TSX - The Globe and Mail

Jun 02, 2025
pulisher
May 31, 2025

SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 31, 2025
pulisher
May 30, 2025

Why Is Bausch (BHC) Down 13% Since Last Earnings Report? - Yahoo Finance

May 30, 2025
pulisher
May 29, 2025

Intraocular Lens Market Is Booming So Rapidly 2025-2032 -Bausch - openPR.com

May 29, 2025
pulisher
May 29, 2025

With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Choroidal Neovascularization Market: Insights Into Retinal - openPR.com

May 29, 2025
pulisher
May 28, 2025

Verteporfin Market Projected to Witness Increased UtilizationNovartis, Valeant Pharmaceuticals - openPR.com

May 28, 2025
pulisher
May 28, 2025

Actinic Keratosis Market Poised Boom | Almirall, S.A, Bausch - openPR.com

May 28, 2025
pulisher
May 26, 2025

Bausch Health’s $7.9 Billion Refinancing Transaction - Global Legal Chronicle

May 26, 2025
pulisher
May 24, 2025

Research Analysts Offer Predictions for TSE:BHC Q2 Earnings - Defense World

May 24, 2025
pulisher
May 24, 2025

Equities Analysts Set Expectations for BHC Q3 Earnings - Defense World

May 24, 2025
pulisher
May 22, 2025

Colonoscopy Bowel Preparation Drugs Market Detailed Analysis - openPR.com

May 22, 2025
pulisher
May 21, 2025

Facial Injectable Market Forecasts Report 2025-2030, - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Bausch Health Companies IncEnters Agreements With Icahn, Paulson, Kavanagh GroupsSEC Filing - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Bausch Health and Bausch + Lomb Brief: Cos Have Cited Amendment to Definitive Proxy Statement Relating to 2025 Annual Meeting of Shareholders On May 21, 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Bausch + Lomb’s New Board Agreements Announced - TipRanks

May 21, 2025
pulisher
May 21, 2025

Bausch Health Signs New Board Agreements - TipRanks

May 21, 2025
pulisher
May 21, 2025

Bausch Health Companies Inc. (NYSE:BHC) Receives Average Rating of “Reduce” from Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

Bausch Health Companies (TSE:BHC) Stock Price Up 1.4% – Time to Buy? - Defense World

May 20, 2025
pulisher
May 19, 2025

Photodynamic Therapy Market Trends Report 2025-2033, Competitive Analysis of Gladerma, Sun Pharma, Biofrontera, Lumibird, Bausch Health, Soligenix, Modulight, and Theralase TechnologiesResearchAndMarkets.com | FinancialContent - FinancialContent

May 19, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Invests $97,000 in Bausch Health Companies Inc. (NYSE:BHC) - Defense World

May 19, 2025
pulisher
May 16, 2025

Global Cataract Surgery Devices Market to grow at a CAGR of 5.50% - openPR.com

May 16, 2025
pulisher
May 16, 2025

Bausch Health Companies Inc. (NYSE:BHC) Stake Lessened by Stifel Financial Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Bausch, Mylan Settle Patent Suit Over Generic IBS Drugs - Law360

May 15, 2025
pulisher
May 15, 2025

Bausch Health’s CFO Steps In as Interim CAO - TipRanks

May 15, 2025
pulisher
May 15, 2025

India Ophthalmic Devices Market Forecast Report 2025-2033, - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Genital Herpes Treatment Market reached US$ 1,143.19 million - openPR.com

May 15, 2025
pulisher
May 15, 2025

Hyperopia Treatment Market Growth, Trends & Opportunities - openPR.com

May 15, 2025
pulisher
May 14, 2025

Bausch Health Elects New Board at Annual Meeting - TipRanks

May 14, 2025
pulisher
May 14, 2025

Bausch Health Announces 2025 Annual Meeting of Shareholder Results - ACCESS Newswire

May 14, 2025
pulisher
May 14, 2025

Bausch Health Annual Meeting: Shareholders Back Board Slate, Executive Pay, and New Stock Plan - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Otoplasty Market Is Booming Worldwide 2025-2032 | Allergan,Bausch Health Companies,Sientra - openPR.com

May 14, 2025
pulisher
May 14, 2025

Bausch + Lomb Brief: Announcing the U.S. Launch of Zenlens CHROMA HOA scleral contact lenses - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Medical Lasers Market 2025-2032: Emerging Trends, Growth - openPR.com

May 14, 2025
pulisher
May 13, 2025

Oral Mucositis Market Outlook: Trends & Forecast 2024-2031 | - openPR.com

May 13, 2025
pulisher
May 13, 2025

Raymond James Financial Inc. Makes New Investment in Bausch Health Companies Inc. (NYSE:BHC) - Defense World

May 13, 2025
pulisher
May 12, 2025

Biopharma Dealmaking Quarterly Statistics, Q2 2013 - insights.citeline.com

May 12, 2025
pulisher
May 09, 2025

Mariner LLC Sells 2,340 Shares of Bausch Health Companies Inc. (NYSE:BHC) - Defense World

May 09, 2025
pulisher
May 07, 2025

Bausch health outlines 2025 guidance with 4-5% revenue and EBITDA growth amid strategic refinancing - MSN

May 07, 2025
pulisher
May 07, 2025

Scar Treatment Market Detailed In New Research Report 2025 | - openPR.com

May 07, 2025
pulisher
May 07, 2025

Bausch Health Companies Inc. (BHC): Among Billionaire John Paulson’s Stocks with Huge Upside Potential - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Bausch Health shares fall 39% following InvestingPro’s overvalued warning By Investing.com - Investing.com

May 07, 2025
pulisher
May 07, 2025

Bausch + Lomb Brief: Says Received European CE Mark Approval for Preloaded LuxLife Full Range of Vision Intraocular Lens - marketscreener.com

May 07, 2025
pulisher
May 06, 2025

Bausch Health (BHC) Data Highlights Reduced Rehospitalization wi - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bausch Health (BHC) Data Highlights Reduced Rehospitalization with Xifaxan Use | BHC Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bausch Health Up 3.5% In US Premarket As Says New Analysis Suggests efficacy of Xifaxan - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization - voiceofalexandria.com

May 06, 2025
pulisher
May 06, 2025

Bausch Health (BHC) Target Price Reduced by Raymond James | BHC Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bausch Health (BHC) Faces Revised Price Target by Raymond James | BHC Stock News - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Bausch Health price target cut to $8 by Raymond James - Investing.com Nigeria

May 05, 2025
pulisher
May 05, 2025

Dry Eye Syndrome Treatment Market Set to Witness Significant - openPR.com

May 05, 2025
pulisher
May 02, 2025

BHC: RBC Capital Raises Price Target for Bausch Health Companies | BHC Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Bausch Health Companies Inc. (NYSE:BHC) Q1 2025 Earnings Call Transcript - Insider Monkey

May 02, 2025
$8.425
price down icon 3.28%
drug_manufacturers_specialty_generic RDY
$14.62
price down icon 0.81%
$124.86
price down icon 0.01%
drug_manufacturers_specialty_generic HCM
$14.21
price up icon 2.99%
$324.39
price down icon 0.70%
$17.29
price up icon 0.03%
자본화:     |  볼륨(24시간):